Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11601
Global X MSCI China Consumer Discretionary ETF
CHIQ
$99.6M
| $89.7K | ﹤0.01% |
4,728
+4,717
| +42,882% | +$97.1K |
2024 Q3
1 quarter
|
|
11602
PUT
iShare MSCI Eurozone ETF
EZU
$9.25B
| $89.7K | ﹤0.01% |
1,900
-20,600
| -92% | -$1.01M |
2021 Q2
14 quarters
|
|
|
HITI
11603
PUT
High Tide
HITI
$243M
| $89.6K | ﹤0.01% |
29,000
+28,600
| +7,150% | +$81.1K |
2022 Q4
8 quarters
|
|
11604
CALL
Quince Therapeutics
QNCX
$27.2M
| $89.6K | ﹤0.01% |
240
+207
| +627% | +$62.2K |
2024 Q1
3 quarters
|
|
11605
PUT
Sixth Street Specialty
TSLX
$1.64B
| $89.5K | ﹤0.01% |
4,200
-14,600
| -78% | -$303K |
2022 Q2
10 quarters
|
|
11606
CALL
Ascent Industries
ACNT
$123M
| $89.4K | ﹤0.01% |
8,000
+7,300
| +1,043% | +$75.1K |
2024 Q3
1 quarter
|
|
|
DMF
11607
DELISTED
BNY Mellon Municipal Income
DMF
| $89.2K | ﹤0.01% |
+12,566
| New | +$91.1K |
2024 Q4
0 quarters
|
|
11608
CALL
Bristow Group
VTOL
$1.18B
| $89.2K | ﹤0.01% |
2,600
-500
| -16% | -$17.7K |
2023 Q1
7 quarters
|
|
11609
CALL
State Street SPDR Dow Jones REIT ETF
RWR
$1.74B
| $89K | ﹤0.01% |
900
-600
| -40% | -$62.5K |
2022 Q4
8 quarters
|
|
11610
PUT
SLR Investment Corp
SLRC
$624M
| $88.9K | ﹤0.01% |
5,500
-1,500
| -21% | -$23.8K |
2022 Q4
8 quarters
|
|
11611
PUT
National Vision
EYE
$1.33B
| $88.6K | ﹤0.01% |
8,500
+3,800
| +81% | +$41.6K |
2022 Q3
9 quarters
|
|
|
QTEX
11612
QTREX Quantum
QTEX
$111M
| $88.5K | ﹤0.01% |
86,763
+70,159
| +423% | +$89.7K |
2024 Q1
3 quarters
|
|
11613
Modular Medical
MODD
$21.7M
| $88.4K | ﹤0.01% |
+2,150
| New | +$125K |
2024 Q4
0 quarters
|
|
11614
CALL
Vanguard Total International Bond ETF
BNDX
$82.3B
| $88.3K | ﹤0.01% |
+1,800
| New | +$90K |
2024 Q4
0 quarters
|
|
11615
CALL
Telos
TLS
$322M
| $88.2K | ﹤0.01% |
25,800
-3,200
| -11% | -$11.4K |
2022 Q4
8 quarters
|
|
11616
GraniteShares 2x Long AMZN Daily ETF
AMZZ
$48.8M
| $88.2K | ﹤0.01% |
2,553
+1,620
| +174% | +$49.9K |
2024 Q3
1 quarter
|
|
11617
PUT
Cohu
COHU
$3.35B
| $88.1K | ﹤0.01% |
3,300
-3,100
| -48% | -$81.1K |
2022 Q4
8 quarters
|
|
11618
AdvisorShares Pure Cannabis ETF
YOLO
$31.9M
| $88.1K | ﹤0.01% |
36,397
+9,205
| +34% | +$26.3K |
2022 Q4
8 quarters
|
|
11619
PUT
MacroGenics
MGNX
$226M
| $88.1K | ﹤0.01% |
27,100
-31,100
| -53% | -$112K |
2022 Q4
8 quarters
|
|
11620
PUT
Solid Power
SLDP
$548M
| $87.9K | ﹤0.01% |
46,500
+42,100
| +957% | +$52.1K |
2021 Q4
12 quarters
|
|
11621
PUT
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
| $87.8K | ﹤0.01% |
3,400
+1,800
| +113% | +$49.9K |
2024 Q3
1 quarter
|
|
11622
PUT
LifeVantage
LFVN
$75.5M
| $87.7K | ﹤0.01% |
5,000
+4,700
| +1,567% | +$65.9K |
2024 Q3
1 quarter
|
|
|
TNMG
11623
TNL Mediagene
TNMG
$3.06M
| $87.7K | ﹤0.01% |
+69
| New | +$106K |
2024 Q4
0 quarters
|
|
11624
Invesco Senior Income Trust
VVR
$442M
| $87.6K | ﹤0.01% |
+22,185
| New | +$87.4K |
2024 Q4
0 quarters
|
|
|
AVNS
11625
CALL
DELISTED
Avanos Medical
AVNS
| $87.6K | ﹤0.01% |
5,500
+100
| +2% | +$1.98K |
2022 Q4
8 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.